First findings published: Psoriasis and Beyond Global Study

23 March 2022


Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey

The Psoriasis & Beyond study gathered input from nearly 5,000 participants to determine patients’ understanding of the systemic nature of psoriatic disease and the associated burden of living with it.

What was learned?

  • The results of this study demonstrate that despite most patients knowing the term "psoriatic disease," they are unaware of the systemic nature of the disease, and its increased risk of comorbidities.
  • A significant impact of psoriatic disease can be seen on physical appearance, work, quality of life, emotions, and relationships.
  • According to research, an average of 2–3 years passed before a confirmed diagnosis of psoriasis and psoriatic arthritis was made after the first symptom appeared.
  • In addition to this, many patients with psoriasis are also at risk for developing psoriatic arthritis
  • An interim analysis reveals that optimal management of psoriatic disease requires patient education, productive dialogue, and shared decision-making between patients and healthcare practitioners.

You can read this newly published article in full in Dermatology and Therapy 2022.